Shorla Oncology
Founded 2018
About Shorla Oncology
Shorla Oncology specializes in the development and commercialization of innovative oncology drugs, focusing on treatments for women's and pediatric cancers. The company is dedicated to delivering life-saving treatments by addressing unmet needs in the oncology sector. Shorla Oncology's portfolio includes a range of oncology solutions designed to improve patient outcomes and provide more effective treatment options. The company's commitment to innovation in cancer therapy is reflected in its ongoing research and development efforts, aiming to bring new oncology products to the market.
Company Facts
- Founded: 2018
- Legal name: Shorla Pharma Ltd
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $29.6M
- Last round: Series Unknown (Feb 2026)
- Website: shorlaoncology.com
- Phone: 353 (052) 618 4362
Social Profiles
Canonical: https://fsome.com/organization/shorla-oncology-8316431 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.